Effect of Methionine on AMD1 Gene Expression in Prostate Cancer Cells

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.21387
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P. Methionine dependency and cancer treatment. Cancer Treat Rev. 2003;29(6):489–499. doi:10.1016/s0305-7372(03)00118-x
   PubMed Web of Science ®Google Scholar
• Kokkinakis DM, Hoffman RM, Frenkel EP, Wick JB, Han Q, Xu M, Tan Y, Schold SC. Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice. Cancer Res. 2001;61(10):4017–4023.
   PubMed Web of Science ®Google Scholar
• Stern PH, Hoffman RM. Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro. 1984;20(8):663–670. doi:10.1007/BF02619617
   PubMedGoogle Scholar
• Tisdale MJ. Effect of methionine deprivation on methylation and synthesis of macromolecules. Br J Cancer. 1980;42(1):121–128. doi:10.1038/bjc.1980.210
   PubMed Web of Science ®Google Scholar
• Judde JG, Ellis M, Frost P. Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res. 1989;49(17):4859–4865.
   PubMed Web of Science ®Google Scholar
• Gupta ED, Pachauri M, Ghosh PC, Rajam MV. Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line. Tumour Biol. 2016;37(1):1159–1171. doi:10.1007/s13277-015-3912-2
   PubMedGoogle Scholar
• Gerner EW. Cancer chemoprevention locks onto a new polyamine metabolic target. Cancer Prev Res (Phila)). 2010;3(2):125–127. doi:10.1158/1940-6207.CAPR-09-0252
   PubMed Web of Science ®Google Scholar
• Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Asia Pac J Clin Oncol. 2013;9:29–39.
   PubMed Web of Science ®Google Scholar
• Moyad MA, Newton RU, Tunn UW, Gruca D. Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy. Res Rep Urol. 2016;8:133–143. doi:10.2147/RRU.S107852
   PubMed Web of Science ®Google Scholar
• Wang XS, Zhao F, Fisch MJ, O'Mara AM, Cella D, Mendoza TR, Cleeland CS. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer-Am Cancer Soc. 2014;120:425–432.
   PubMed Web of Science ®Google Scholar
• Drummond FJ, Kinnear H, O'Leary E, Donnelly Gavin A, Sharp L. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study. J Cancer Surviv. 2015;9:361–372. doi:10.1007/s11764-014-0419-6
   PubMed Web of Science ®Google Scholar
• Bourke L, Gilbert S, Hooper R, Steed LA, Joshi M, Catto JW, Saxton JM, Rosario DJ. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol. 2014;65(5):865–872. doi:10.1016/j.eururo.2013.09.040
   PubMed Web of Science ®Google Scholar
• Schwedhelm C, Boeing H, Hoffmann G, Aleksandrova K, Schwingshackl L. Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies. Nutr Rev. 2016;74(12):737–748. doi:10.1093/nutrit/nuw045
   PubMed Web of Science ®Google Scholar
• Skolarus TA, Wolf AM, Erb NL, Brooks DD, Rivers BM, Underwood WR, Salner AL, Zelefsky MJ, Aragon-Ching JB, Slovin SF, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014;64(4):225–249. doi:10.3322/caac.21234
   PubMed Web of Science ®Google Scholar
• Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–5830. doi:10.1200/JCO.2005.01.230
   PubMed Web of Science ®Google Scholar
• Blanchard CM, Courneya KS, Stein K. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. JCO. 2008;26(13):2198–2204. doi:10.1200/JCO.2007.14.6217
   PubMed Web of Science ®Google Scholar
• Stobaus N, Muller MJ, Kupferling S, Schulzke JD, Norman K. Low recent protein intake predicts cancer-related fatigue and increased mortality in patients with advanced tumor disease undergoing chemotherapy. Nutr Cancer. 2015;67(5):818–824. doi:10.1080/01635581.2015.1040520
   PubMed Web of Science ®Google Scholar
• Gerner EW, Meyskens FJ. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004;4(10):781–792. doi:10.1038/nrc1454
   PubMed Web of Science ®Google Scholar
• Atala A. Re: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer. J Urol. 2018;199(2):344–346. doi:10.1016/j.juro.2017.11.019
   PubMed Web of Science ®Google Scholar
• Fu YM, Yu ZX, Li YQ, Ge X, Sanchez PJ, Fu X, Meadows GG. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells. Nutr Cancer. 2003;45(1):60–73. doi:10.1207/S15327914NC4501_8
   PubMed Web of Science ®Google Scholar
• Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12(1):21–35. doi:10.1038/nrm3025
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10(5):307–318. doi:10.1038/nrm2672
   PubMed Web of Science ®Google Scholar
• Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science. 2013;339(6125):1323–1328. doi:10.1126/science.1228792
   PubMed Web of Science ®Google Scholar
• Lamming DW, Sabatini DM. A Central role for mTOR in lipid homeostasis. Cell Metab. 2013;18(4):465–469. doi:10.1016/j.cmet.2013.08.002
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–293. doi:10.1016/j.cell.2012.03.017
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci. 2013;126(Pt 8):1713–1719. doi:10.1242/jcs.125773
   PubMed Web of Science ®Google Scholar
• Ganley IG, Lam DH, Wang J, Ding X, Chen S, Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem. 2009;284(18):12297–12305. doi:10.1074/jbc.M900573200
   PubMed Web of Science ®Google Scholar
• Scuoppo C, Miething C, Lindqvist L, Reyes J, Ruse C, Appelmann I, Yoon S, Krasnitz A, Teruya-Feldstein J, Pappin D, et al. A tumour suppressor network relying on the polyamine-hypusine axis. Nature. 2012;487(7406):244–248. doi:10.1038/nature11126
   PubMed Web of Science ®Google Scholar